Quote:

---

The second dispute is ongoing. It involves more wage-related issues and gets in to more detail around termination "for cause" or "not for cause." Certain parts were adjudicated and dismissed, mostly in favor of CYDY. There is a trial scheduled in April 2022 for the remaining parts.

---

The wage claims were thrown out. What is at dispute is the 8.3 million restricted shares that would not be awarded if Pestell was fired for cause. Purposefully delaying the start of a clinical trial certainly would come under "for cause".

Of interest is that Pestell has claimed 8.3 million voting shares in the 13d. Most certainly he has sold all of his other shares and the 8.3 million is reliant upon the disputed shares.